Fetal Leydig cells: What we know and what we don't
Molecular Reproduction and Development · 2024-03 · 91 (3)
DOI: 10.1002/mrd.23739 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Reproduction and Development, online erschienen am 13.03.2024. Verfasst von Keer Jiang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Leydig Cells, Androgens. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
During male fetal development, testosterone plays an essential role in the differentiation and maturation of the male reproductive system. Deficient fetal testosterone production can result in variations of sex differentiation that may cause infertility and even increased tumor incidence later in life. Fetal Leydig cells in the fetal testis are the major androgen source in mammals. Although fetal and adult Leydig cells are similar in their functions, they are two distinct cell types, and therefore, the knowledge of adult Leydig cells cannot be directly applied to understanding fetal Leydig cells. This review summarizes our current knowledge of fetal Leydig cells regarding their cell biology, developmental biology, and androgen production regulation in rodents and human. Fetal Leydig cells are present in basement membrane‐enclosed clusters in between testis cords. They originate from the mesonephros mesenchyme and the coelomic epithelium and start to differentiate upon receiving a Desert Hedgehog signal from Sertoli cells or being released from a NOTCH signal from endothelial cells. Mature fetal Leydig cells produce androgens. Human fetal Leydig cell steroidogenesis is LHCGR (Luteinizing Hormone Chronic Gonadotropin Receptor) dependent, while rodents are not, although other Gα s ‐protein coupled receptors might be involved in rodent steroidogenesis regulation. Fetal steroidogenesis ceases after sex differentiation is completed, and some fetal Leydig cells dedifferentiate to serve as stem cells for adult testicular cell types. Significant gaps are acknowledged: (1) Why are adult and fetal Leydig cells different? (2) What are bona fide progenitor and fetal Leydig cell markers? (3) Which signaling pathways and transcription factors regulate fetal Leydig cell steroidogenesis? It is critical to discover answers to these questions so that we can understand vulnerable targets in fetal Leydig cells and the mechanisms for androgen production that when disrupted, leads to variations in sex differentiation that range from subtle to complete sex reversal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Cellular and Molecular Biology Graduate Program, University of Wisconsin-Madison, Madison, Wisconsin, USA.
ORCID-Profile: Keer Jiang, Joan S Jorgensen
Förderung
- NICHD NIH HHS
- National Institutes of Health
Zitieren
APA
Jiang, K., & Jorgensen, J. S. (2024). Fetal Leydig cells: What we know and what we don't. Molecular Reproduction and Development, 91(3). https://doi.org/10.1002/mrd.23739
Vancouver
Jiang K, Jorgensen JS. Fetal Leydig cells: What we know and what we don't. Molecular Reproduction and Development. 2024;91(3). doi:10.1002/mrd.23739
BibTeX
@article{Jiang2024,
author = {Jiang, Keer and Jorgensen, Joan S},
title = {Fetal Leydig cells: What we know and what we don't},
journal = {Molecular Reproduction and Development},
year = {2024},
volume = {91},
number = {3},
doi = {10.1002/mrd.23739}
}
EUVIMED